NOMEPRAMAL

This brand name is authorized in Nigeria.

Active ingredients

The drug NOMEPRAMAL contains a combination of these active pharmaceutical ingredients (APIs):

1	Artemisinin UNII 6A9O50735X - ARTENIMOL
	Artemisinin is used in the treatment of malaria due to species Plasmodium.
	Read more about Artemisinin
2	UNII 854D7K8LXB - PIPERAQUINE PHOSPHATE
	Read more about

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7965	Tablet	Nomepramal Tablet TAB 40 mg; 320 mg 1 X 9TABS	133 NF-PP-325934 Nomepramal Tablet Dihydroartemisinin: 40 mg Piperaquine Phosphate: 320 mg Excipients: q.s. Colour: Indigo Carmine Dihydroartemisinin: 40 mg Piperaquine Phosphate: 320 mg Excipients: q.s. Colour: Indigo Carmine Drugs Imported Products 1x9 Tabs Over The Counter (OTC) 2/9/2023 NOMEDI PHARMACEUTICALS LIMITED, 387 AGEGE MOTOR ROAD MUSHIN LAGOS CORAL LABORATORIES LIMITED, PLOT NO 57 /1 (16) BHENSLORE, DUNETHA NANI DAMAN - 396 210	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF07		P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7965